NEW YORK, Dec. 17, 2025 /PRNewswire/ — With the holiday season approaching, finding a gift that is both stylish and practical is the perfect way to delight family and friends. The JustHang Squeegee, with its thoughtful features and sleek design, is quickly becoming a highly sought-after household gift this season.

JustHang Squeegee pioneers a built-in hook design that allows effortless hanging on doors, walls, bathroom towel racks, or glass edges without drilling. This makes daily storage more convenient and organized. Featuring an integrated silicone design, it stays securely in place even when placed on flat surfaces. It provides effortless handling for users of all ages, balancing practicality with safety.

The JustHang Squeegee is celebrated for its thoughtful design, blending sleek minimalism with practical functionality. Its design excellence has been recognized with the American Good Design 2025 Bronze Award. In addition, it has received praise from North American media as “Best of Best” Shower Squeegee and earned high marks from an independent German testing team, reflecting widespread appreciation for its quality and innovative approach. This high regard is mirrored in customer enthusiasm:

• “This is PERFECT. I’m even thinking it might be a great gift item. We are all tired of getting things we don’t need or don’t work. This is practical, yet’gifty” – Amazon Customer Carol
• “I’ve had other squeegees before but this one has a heavier feel, a fantastic grip, and an amazing blade to clean the glass. Might buy more for Xmas gifts!” – Amazon Customer Grampadicky

As a holiday gift, the JustHang Squeegee suits a variety of recipients:

• For Parents: It makes daily cleaning effortless and worry-free, eliminating concerns about water stains.
• For the Young and Active: It’s easy to use and comes in a range of vibrant colour options. Fun to use and clear small messes like crumbs from tabletops, too.
• For Friends and Co-workers: A gift that combines aesthetics and practicality. It fits in all house decor and is suitable for a range of surfaces.

This holiday season, consider the JustHang Squeegee as more than a daily cleaning tool, it is a thoughtful gift choice that brings order and warmth to everyday life. During December 17 – 25, dancemoon will offer up to 33% off the JustHang Squeegee. To place an order, please visit dancemoon’s Amazon store and Shopify.

Or follow dancemoon on social media to stay updated with the latest campaigns:

Instagram: https://www.instagram.com/dancemoon.global/ 
TikTok: https://www.tiktok.com/@dancemoon.official 
Facebook: https://www.facebook.com/dancemoonofficial 
YouTube: https://www.youtube.com/@dancemoonofficial 

About dancemoon

Driven by a passion for innovative design, dancemoon infuses the beauty and emotion of the moon into each product. Beyond offering household tools, dancemoon combines innovation with minimalist design to create products that make household tasks simple and no longer a burden but an enjoyable part of life. With a vision to become the leading brand of minimalist lifestyle, dancemoon is committed to blending minimalism with household tools, bringing bliss into your daily life.

CONTACT: info@dancemoon.com 

BEIJING, Dec. 17, 2025 /PRNewswire/ — As the winter chill set in, the 27th Harbin Ice-Snow World, a mega carnival of fancy ice and snow sculptures, buildings and entertainment, opened on Wednesday morning.

Situated in “ice city” Harbin in northeast China, this year’s session featuring an all-time-high ice and snow use of 400,000 cubic meters offers visitors an opportunity to embrace the vast promise of icy wonderland.

Covering areas up to 1.2 million square meters, Harbin Ice-Snow World greeted tourists with drum shows, welcome dances and the “first-day ice can” gifts to add to the lively aura there.

Apart from the historically high ice and snow use, this year’s session stands also for an interaction of the “international style” and Chinese culture, said Guo Hongwei, chairman of Harbin Ice and Snow World Co., Ltd.

Ice buildings such as the ice-made Yellow Crane Tower, an analogue of the time-honored landmark of the same name in Wuhan, central China, is brimming with oriental architectural beauty.

Others including the icy “Manneken Pis”, similar to the city landmark of Brussels in Belgium, attest to the friendly ties between China and Belgium, not to mention a Chinese Baroque-style ice scenery complex in the park.

Available also to winter lovers are the upgraded entertainment options there, which include the super-long ice slide that comprises 24 slide-ways, the 120-meter high ferris wheel, AI-powered interactive equipment, and frozen flowers.

On an outdoor dancefloor, “Brother Left and Right”, a host who got this nickname on the park’s “Dream Stage”, accompanied visitors with interactive singing and dancing activities. Its large fantasy show the Chariot of Valor brought spectators a new visual and aural feast.

With newly-built air dome covering 5,000 square meters, travelers can dine and rest in the “warm castle” in wintry days. Foreign travelers are easy to book tickets with passports and overseas payment. Multilingual tour-guide services are also provided in the park.

As a miniature of China’s burgeoning ice and snow economy, the park is welcoming global visitors to jointly explore the icy carnival in Harbin, said Guo.

Original link: https://en.imsilkroad.com/p/348833.html

SEOUL, South Korea, Dec. 17, 2025 /PRNewswire/ — MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreement with Eli Lilly and Company (Lilly) to advance a next-generation therapeutic for obesity. 

MEDI&GENE’s discovery platform is designed to unlock novel therapeutic pathways that have the potential to sustain long-term weight maintenance, lean mass maintenance, and durability of desired metabolic effects.

Under the agreement, Lilly ExploR&D will bring Lilly’s expertise in molecule engineering and development to a MEDI&GENE asset, with the goal to advance the program to clinical trial readiness. Lilly ExploR&D is part of the Lilly Catalyze360 suite of offerings designed to empower biotech innovation by providing access to strategic capital, lab space and technology, and research and development capabilities.

“We are excited to work with Lilly to advance a next-generation obesity drug candidate. We believe this collaboration will accelerate clinical development and help bring differentiated solutions to patients with obesity,” said Min-Jeong Shin, CEO of MEDI&GENE.

Founded in 2021, MEDI&GENE has established a discovery engine centered on metabolic and obesity-related pathways and has identified multiple innovative candidates through its mechanistic platform. The company expects that the collaboration will support the continued advancement of its research initiatives in next-generation obesity therapeutics.

LOS ANGELES, Dec. 17, 2025 /PRNewswire/ — RayNeo announced the December 17 global launch of its flagship RayNeo X3 Pro AR glasses—recently honored by TIME Magazine in its list of “Best Inventions of 2025.” With built-in augmented reality (AR), RayNeo’s X3 Pro will bring next‑generation visual technology to users in the United States and key markets worldwide.

Why TIME Magazine Calls the RayNeo X3 Pro One of the “Best Inventions of 2025”

The X3 Pro is engineered to be a versatile companion for modern life, seamlessly transitioning between productivity and entertainment. It elevates daily routines by enabling hands-free photography, providing real-time translation across languages, assisting with AI-powered note-taking, and enhancing communication. For leisure, it serves as a personal media hub for immersive viewing, gaming, and music. Crucially, its open ecosystem allows users to directly install and interact with popular Android applications like TikTok and YouTube, merging the convenience of a familiar mobile experience with the liberation of augmented reality.

This remarkable versatility is built upon a foundation of comprehensive engineering excellence across four core pillars: visual performance, intelligent processing, intuitive interaction, and an open software ecosystem.

*   Visual Performance: The X3 Pro features the world’s smallest full-color MicroLED optical engine, co-developed with Applied Materials, delivering a bright, high-contrast virtual display with a peak brightness of 6,000 nits for clarity in any environment.

*   Intelligent Processing: Powered by the Snapdragon AR1 platform, the X3 Pro delivers top-tier AI and multimedia performance within an ultra-lightweight frame of just 76 grams (2.7 ounces).

*   Intuitive Interaction: For effortless control across all scenarios, the device integrates multiple inputs: a built-in five-way temple touchpad and voice commands for immediate action, complemented by input options from a paired smartphone or Apple Watch.

*   Open Software Ecosystem: Running on RayNeoOS 2.0 with its innovative AR Application Virtual Machine, the X3 Pro bridges the vast Android app library directly into the user’s field of view, allowing access to apps like WhatsApp, Instagram, and TikTok.

A Clear Choice in the Emerging Full-Color AR Market

In the consumer AR landscape, where only a few AR glasses like the Meta Display also offer full-color, see-through displays, the RayNeo X3 Pro presents itself as a distinctly superior choice, emphasizing openness, visual comfort, and practical usability.

*   Superior Visual Design: Unlike monocular approaches, the X3 Pro employs a true binocular display with dual optical engines and waveguides. This design respects natural binocular vision, significantly reducing eye strain and providing a more immersive, accurate, and comfortable experience for both media consumption and first-person photography.

*   Commitment to an Open Ecosystem: The X3 Pro is built on a foundation of choice. It supports access to leading AI platforms like GPT and provides developers with robust tools (Unity, Android ARDK) to foster an expansive open AR ecosystem. This stands in stark contrast to closed systems, which restrict users to a single vendor’s AI model and application environment, limiting both functionality and long-term flexibility.

*   User-Focused Practical Innovations: While offering comparable battery life, the X3 Pro introduces key practical advantages. It supports use while charging, enabling true all-day usability, and features a dual-touchpad interface for more intuitive and responsive control compared to single-input alternatives.

“The TIME award validates our integrated approach: combining groundbreaking hardware with an open, user-centric platform,” said Howie Li, founder and CEO of RayNeo. “With the launch of the X3 Pro, users will experience a device that adapts to their lives—enhancing productivity and seamlessly integrating into their daily entertainment.”

Global Availability & Pricing:

• Buying Link: RayNeo X3 Pro buying Page
• Launch Date: December 17, 2025
• MSRP: $1,299
• Early Bird（Dec 17- Jan 5）: $1099
• Early Bird Offer: $999 (Available starting November 17 for a limited period)

About RayNeo:

RayNeo is the global leader in consumer Augmented Reality (AR) glasses, dedicated to transforming everyday life for one billion people. As the Official Worldwide Olympic Partner in the AR glasses category, the company represents the forefront of immersive technology. Its product portfolio features the AI-enhanced, full-color display X Series and the portable, large-screen Air Series, designed for versatility and high-quality viewing. According to Counterpoint Research, RayNeo dominated the global AR glasses market in Q3 2025, capturing a 24% market share and securing the top position worldwide.

SHANGHAI and SANTA BARBARA, Calif., Dec. 17, 2025 /PRNewswire/ — Rona Therapeutics, a global leader in next-generation RNAi medicines, today announced the submission of RN5681 to the Australian Human Research Ethics Committee (HREC), advancing the company’s first bi-valent siRNA into clinical development. The Phase 1 trial is expected to begin dosing in Q1 2026.

RN5681 is a GalNAc-conjugated, dual-targeting siRNA designed to simultaneously silence both PCSK9 and LPA, two genetically validated and complementary drivers of atherosclerotic cardiovascular disease. By unifying LDL-C lowering and Lp(a) reduction within a single molecule, RN5681 aims to deliver deep, durable lipid improvement and address persistent residual risk not resolved by current therapies.

“As a clinician who has helped bring lipid-lowering therapies to patients, I see exceptional promise in a bi-valent siRNA approach,” said Alex DePaoli, MD, CMO. “RN5681 has the potential to expand the treatment paradigm by tackling two of the most important cardiovascular risk factors with unimolecular medicine that could potentially be easily dosed every 6-12 months.”

Dr. DePaoli recently presented Rona’s bi- and multi-target siRNA platform at the 22^nd Global Cardiovascular Clinical Trialists Forum (CVCT, Washington, DC). The visibility of Rona’s science at a premier global cardiovascular meeting underscores rapid recognition of the company’s leadership in multi-target siRNA design and development.

“RN5681 is the first bi-valent siRNA therapy emerging from our pioneering plug-and-play technology platform,” said Stella Shi, CEO. “This filing marks an important step toward bringing next generation of RNAi therapy to patients globally with transformative cardiovascular benefit. We are excited about future multi-valency siRNA breakthrough opportunities in cardiometabolic and obesity areas to address comorbidities.  

About Rona Therapeutics

Rona Therapeutics is a world-leading RNAi therapeutics company dedicated to addressing cardiometabolic, obesity and degenerative diseases with next generation RNA technology platform. Since its inception in 2021, the Company has progressed four programs into the clinic leveraging its proprietary platform in delivery, multi-valency and oligo chemistry. The Company has raised approximately $200M from global blue-chip healthcare investors and strategic partners.